Form 13-F position report

* INTEGRA LIFESCIENCES HLDGS

Reported by VANGUARD GROUP INC

IART CUSIP 457985208 Manager CIK 0000102909

Reported 7,580,967 shares, down 162,961 (2.1%) from the prior quarter.

Reported value 22.2%; share count -2.1% vs. the prior quarter.

Reduced
% of reported 13F value < 0.01% This manager · Q4 2024
Shares 7,580,967 Quarter-end amount reported
Reported value $171,936,332 Fair value at quarter end
Consecutive quarters held 47 Through Q4 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-03-31 456509000
2021-06-30 453899000
2021-09-30 456925000
2021-12-31 446094000
2022-03-31 421167000
2022-06-30 364153000
2022-09-30 293538000
2022-12-31 400774848
2023-03-31 403329535
2023-06-30 291511342
2023-09-30 273434824
2023-12-31 305407135
2024-03-31 247468190
2024-06-30 226498052
2024-09-30 140707172
2024-12-31 171936332
2025-03-31 165290649
2025-06-30 92985655
2025-09-30 105742890
2025-12-31 89555950

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for * INTEGRA LIFESCIENCES HLDGS held by VANGUARD GROUP INC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2025 Reduced 7,210,624 -168,503 (-2.3%) < 0.01% $89,555,950 2026-01-29
Q3 2025 Reduced 7,379,127 -199,166 (-2.6%) < 0.01% $105,742,890 2025-11-07
Q2 2025 Added 7,578,293 +61,665 (0.8%) < 0.01% $92,985,655 2025-08-11
Q1 2025 Reduced 7,516,628 -64,339 (-0.8%) < 0.01% $165,290,649 2025-05-09
Q4 2024 Reduced 7,580,967 -162,961 (-2.1%) < 0.01% $171,936,332 2025-02-11
Q3 2024 Reduced 7,743,928 -28,826 (-0.4%) < 0.01% $140,707,172 2024-11-13
Q2 2024 Added 7,772,754 +791,987 (11.3%) < 0.01% $226,498,052 2024-08-13
Q1 2024 Reduced 6,980,767 -32,026 (-0.5%) < 0.01% $247,468,190 2024-05-10
Q4 2023 Reduced 7,012,793 -147,061 (-2.1%) < 0.01% $305,407,135 2024-02-14
Q3 2023 Added 7,159,854 +72,294 (1.0%) < 0.01% $273,434,824 2023-11-14
Q2 2023 Added 7,087,560 +62,137 (0.9%) < 0.01% $291,511,342 2023-08-14
Q1 2023 Reduced 7,025,423 -122,336 (-1.7%) 0.01% $403,329,535 2023-05-15
Q4 2022 Added 7,147,759 +218,153 (3.1%) 0.01% $400,774,848 2023-02-10
Q3 2022 Added 6,929,606 +189,772 (2.8%) < 0.01% $293,538,000 2022-11-14
Q2 2022 Added 6,739,834 +185,727 (2.8%) 0.01% $364,153,000 2022-08-12
Q1 2022 Reduced 6,554,107 -105,015 (-1.6%) < 0.01% $421,167,000 2022-05-13
Q4 2021 Reduced 6,659,122 -13,264 (-0.2%) 0.01% $446,094,000 2022-02-14
Q3 2021 Added 6,672,386 +20,888 (0.3%) 0.01% $456,925,000 2021-11-12
Q2 2021 Added 6,651,498 +44,050 (0.7%) 0.01% $453,899,000 2021-08-13
Q1 2021 Added 6,607,448 +132,907 (2.1%) 0.01% $456,509,000 2021-05-14
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

264 managers reported * INTEGRA LIFESCIENCES HLDGS for Q4 2024.

Managers reporting * INTEGRA LIFESCIENCES HLDGS in Q4 2024.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Added 11,128,390 +242,167 < 0.01% $252,391,884 2 qtrs
VANGUARD GROUP INC This report Reduced 7,580,967 -162,961 < 0.01% $171,936,332 47 qtrs
MORGAN STANLEY Added 5,321,243 +64,887 < 0.01% $120,685,817 47 qtrs
FULLER & THALER ASSET MANAGEMENT INC Reduced 3,932,279 -35,283 0.34% $89,184,088 23 qtrs
STATE STREET CORPORATION Added 2,852,917 +26,662 < 0.01% $64,704,158 47 qtrs
Rubric Capital Management LP Added 2,618,341 +2,325,258 0.76% $59,383,974 2 qtrs
ALLIANCEBERNSTEIN L P Reduced 2,578,393 -443,597 0.02% $58,477,953 47 qtrs
WELLINGTON MANAGEMENT GROUP LLP Added 2,506,138 +303,779 0.01% $56,839,209 33 qtrs
DIMENSIONAL FUND ADVISORS LP Reduced 2,371,725 -32,124 0.01% $53,790,159 47 qtrs
Invesco Ltd Reduced 2,066,285 -4,772 < 0.01% $46,863,345 47 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2024
Filed
February 11, 2025
Filing type
13F-HR
Position type
COM NEW

Voting authority reported

Sole
0
Shared
91,018
None
7,489,949

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.